Literature DB >> 19906913

Viral mutagenesis as a means for generating novel proteins.

John N Davis1, Anthony N van den Pol.   

Abstract

We demonstrate that a mutation-prone virus engineered to express a foreign gene is an expedient means for generating novel mutant nonviral proteins in mammalian cells. Using vesicular stomatitis virus to express a gene coding for a fluorescent DsRed protein, a number of green mutant variants including a new variant not previously described were rapidly isolated from infected cells, sequenced, and cloned. Similar methods may be useful in the development of physiologically sensitive fluorescent reporter proteins and directed evolution or mutagenesis of proteins in general.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906913      PMCID: PMC2812339          DOI: 10.1128/JVI.01747-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Mutation rates among RNA viruses.

Authors:  J W Drake; J J Holland
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 2.  Advances in generating functional diversity for directed protein evolution.

Authors:  Amol V Shivange; Jan Marienhagen; Hemanshu Mundhada; Alexander Schenk; Ulrich Schwaneberg
Journal:  Curr Opin Chem Biol       Date:  2009-03-02       Impact factor: 8.822

3.  Improving the photostability of bright monomeric orange and red fluorescent proteins.

Authors:  Nathan C Shaner; Michael Z Lin; Michael R McKeown; Paul A Steinbach; Kristin L Hazelwood; Michael W Davidson; Roger Y Tsien
Journal:  Nat Methods       Date:  2008-05-04       Impact factor: 28.547

4.  A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals.

Authors:  Elizabeth Ramsburg; Jean Publicover; Linda Buonocore; Amanda Poholek; Michael Robek; Amy Palin; John K Rose
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Evaluation of recombinant alphaviruses as vectors in gene therapy.

Authors:  J J Wahlfors; S A Zullo; S Loimas; D M Nelson; R A Morgan
Journal:  Gene Ther       Date:  2000-03       Impact factor: 5.250

6.  Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas.

Authors:  Georgia Paraskevakou; Cory Allen; Takafumi Nakamura; Paula Zollman; C David James; Kah Whye Peng; Mark Schroeder; Stephen J Russell; Evanthia Galanis
Journal:  Mol Ther       Date:  2007-02-13       Impact factor: 11.454

7.  Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells.

Authors:  Guido Wollmann; Vitaliy Rogulin; Ian Simon; John K Rose; Anthony N van den Pol
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

8.  Conversion of red fluorescent protein into a bright blue probe.

Authors:  Oksana M Subach; Illia S Gundorov; Masami Yoshimura; Fedor V Subach; Jinghang Zhang; David Grüenwald; Ekaterina A Souslova; Dmitriy M Chudakov; Vladislav V Verkhusha
Journal:  Chem Biol       Date:  2008-10-20

9.  Viral strategies for studying the brain, including a replication-restricted self-amplifying delta-G vesicular stomatis virus that rapidly expresses transgenes in brain and can generate a multicolor golgi-like expression.

Authors:  Anthony N van den Pol; Koray Ozduman; Guido Wollmann; Winson S C Ho; Ian Simon; Yang Yao; John K Rose; Prabhat Ghosh
Journal:  J Comp Neurol       Date:  2009-10-20       Impact factor: 3.215

10.  Engineered measles virus as a novel oncolytic therapy against prostate cancer.

Authors:  Pavlos Msaouel; Ianko D Iankov; Cory Allen; John C Morris; Veronika von Messling; Roberto Cattaneo; Michael Koutsilieris; Stephen J Russell; Evanthia Galanis
Journal:  Prostate       Date:  2009-01-01       Impact factor: 4.104

View more
  8 in total

1.  An Adaptable Platform for Directed Evolution in Human Cells.

Authors:  Chet M Berman; Louis J Papa; Samuel J Hendel; Christopher L Moore; Patreece H Suen; Alexander F Weickhardt; Ngoc-Duc Doan; Caiden M Kumar; Taco G Uil; Vincent L Butty; Robert C Hoeben; Matthew D Shoulders
Journal:  J Am Chem Soc       Date:  2018-12-14       Impact factor: 15.419

2.  Directed molecular evolution to design advanced red fluorescent proteins.

Authors:  Fedor V Subach; Kiryl D Piatkevich; Vladislav V Verkhusha
Journal:  Nat Methods       Date:  2011-11-29       Impact factor: 28.547

3.  Highly attenuated recombinant vesicular stomatitis virus VSV-12'GFP displays immunogenic and oncolytic activity.

Authors:  Anthony N van den Pol; John N Davis
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

4.  A system for the continuous directed evolution of biomolecules.

Authors:  Kevin M Esvelt; Jacob C Carlson; David R Liu
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

5.  Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.

Authors:  Sara L Seegers; Connor Frasier; Sarah Greene; Irina V Nesmelova; Valery Z Grdzelishvili
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

6.  Harnessing mutagenic homologous recombination for targeted mutagenesis in vivo by TaGTEAM.

Authors:  Shawn P Finney-Manchester; Narendra Maheshri
Journal:  Nucleic Acids Res       Date:  2013-03-07       Impact factor: 16.971

7.  Retrovolution: HIV-driven evolution of cellular genes and improvement of anticancer drug activation.

Authors:  Paola Rossolillo; Flore Winter; Etienne Simon-Loriere; Sarah Gallois-Montbrun; Matteo Negroni
Journal:  PLoS Genet       Date:  2012-08-23       Impact factor: 5.917

8.  The Methyltransferase Region of Vesicular Stomatitis Virus L Polymerase Is a Target Site for Functional Intramolecular Insertion.

Authors:  Emmanuel Heilmann; Janine Kimpel; Stephan Geley; Andreas Naschberger; Carles Urbiola; Tobias Nolden; Dorotheé von Laer; Guido Wollmann
Journal:  Viruses       Date:  2019-10-26       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.